164 related articles for article (PubMed ID: 15777502)
21. The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families.
Konecny M; Vizvaryova M; Weismanova E; Ilencikova D; Mlkva I; Weismann P; Machackova G; Kausitz J
Neoplasma; 2007; 54(2):137-42. PubMed ID: 17319787
[TBL] [Abstract][Full Text] [Related]
22. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
23. Missense alterations of BRCA1 gene detected in diverse cancer patients.
Shen D; Wu Y; Chillar R; Vadgama JV
Anticancer Res; 2000; 20(2B):1129-32. PubMed ID: 10810408
[TBL] [Abstract][Full Text] [Related]
24. Clustering of variations and haplotype analysis in the highly variable region of exon 11 of BRCA1 in Chinese women with sporadic breast cancer.
Li Y; Zhang S; Xiao C; Su Z; Zhao Y; Chen W; Zhang G
Hum Mutat; 2002 Nov; 20(5):404-5. PubMed ID: 12402341
[TBL] [Abstract][Full Text] [Related]
25. Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP).
Geisler JP; Hatterman-Zogg MA; Rathe JA; Lallas TA; Kirby P; Buller RE
Hum Mutat; 2001 Oct; 18(4):337-44. PubMed ID: 11668617
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
[TBL] [Abstract][Full Text] [Related]
27. Mutation analysis of the breast cancer gene BRCA1 among breast cancer Jordanian females.
Atoum MF; Al-Kayed SA
Saudi Med J; 2004 Jan; 25(1):60-3. PubMed ID: 14758382
[TBL] [Abstract][Full Text] [Related]
28. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
Egeli U; Cecener G; Tunca B; Tasdelen I
Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
[TBL] [Abstract][Full Text] [Related]
29. Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families.
Kim TJ; Lee KM; Choi CH; Lee JW; Lee JH; Bae DS; Kim BG
Oncol Rep; 2006 Mar; 15(3):565-9. PubMed ID: 16465413
[TBL] [Abstract][Full Text] [Related]
30. [Novel BRCA1 gene mutations in breast cancer patients from St. Petersburg].
Tikhomirova OS; Grudinina NA; Golubkov VI; Mandel'shtam MIu; Vasil'ev BV
Genetika; 2007 Sep; 43(9):1263-8. PubMed ID: 17990525
[TBL] [Abstract][Full Text] [Related]
31. Direct genomic multiplex PCR for BRCA1 and application to mutation detection by single-strand conformation and heteroduplex analysis.
Barker DF
Hum Mutat; 2000 Oct; 16(4):334-44. PubMed ID: 11013444
[TBL] [Abstract][Full Text] [Related]
32. [Sequence analysis of BRCA1 gene in young breast cancer patients and/or positive family history].
Hampl M; Plaschke J; Burgemeister R; Schwarz P; Saeger HD; Schackert HK
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):267-72. PubMed ID: 14518257
[TBL] [Abstract][Full Text] [Related]
33. BRCA1 germline mutations in Cypriot breast cancer patients from 26 families with family history.
Hadjisavvas A; Neuhausen SL; Hoffman MD; Adamou A; Newbold RF; Kyriacou KC; Christodoulou CG
Anticancer Res; 2001; 21(5):3307-11. PubMed ID: 11848488
[TBL] [Abstract][Full Text] [Related]
34. Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus.
Loizidou M; Marcou Y; Anastasiadou V; Newbold R; Hadjisavvas A; Kyriacou K
Clin Genet; 2007 Feb; 71(2):165-70. PubMed ID: 17250666
[TBL] [Abstract][Full Text] [Related]
35. [Mutation BRCA1 gene in 186 breast cancer patients].
Lai C; Jiang Z; Song S
Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):483-5. PubMed ID: 11859716
[TBL] [Abstract][Full Text] [Related]
36. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
37. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.
Engert S; Wappenschmidt B; Betz B; Kast K; Kutsche M; Hellebrand H; Goecke TO; Kiechle M; Niederacher D; Schmutzler RK; Meindl A
Hum Mutat; 2008 Jul; 29(7):948-58. PubMed ID: 18431737
[TBL] [Abstract][Full Text] [Related]
38. BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.
Lalloo F; Varley J; Moran A; Ellis D; O'dair L; Pharoah P; Antoniou A; Hartley R; Shenton A; Seal S; Bulman B; Howell A; Evans DG
Eur J Cancer; 2006 May; 42(8):1143-50. PubMed ID: 16644204
[TBL] [Abstract][Full Text] [Related]
39. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
Armaou S; Konstantopoulou I; Anagnostopoulos T; Razis E; Boukovinas I; Xenidis N; Fountzilas G; Yannoukakos D
Eur J Cancer; 2007 Jan; 43(2):443-53. PubMed ID: 17174087
[TBL] [Abstract][Full Text] [Related]
40. BRCA1 mutation screening using restriction endonuclease fingerprinting-single-strand conformation polymorphism in an automated capillary electrophoresis system.
Kringen P; Egedal S; Pedersen JC; Harbitz TB; Tveit KM; Berg K; Børresen-Dale AL; Andersen TI
Electrophoresis; 2002 Dec; 23(24):4085-91. PubMed ID: 12481264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
